查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1927377

按包装类型、温度范围、隔热材料、运输方式和最终用户分類的医药温控包装解决方案市场—2026-2032年全球预测

Pharmaceuticals Temperature Controlled Packaging Solutions Market by Packaging Type, Temperature Range, Insulation Material, Shipping Mode, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医药温控包装解决方案市场规模将达到 149.1 亿美元，到 2026 年将成长至 159.6 亿美元，到 2032 年将达到 241.9 亿美元，复合年增长率为 7.15%。

关键市场统计数据
基准年 2025 149.1亿美元
预计年份：2026年 159.6亿美元
预测年份 2032 241.9亿美元
复合年增长率 (%) 7.15%

将温控包装在製药业中不断演变的角色定位为产品完整性、永续性和供应链韧性的策略性推动因素

医药低温运输环境要求包装解决方案既能保护产品完整性，又能满足不断变化的监管、物流和商业要求。生物製药、细胞和基因疗法以及温度敏感型小分子药物的进步，日益增加了分销的复杂性，迫使相关人员重新评估临床和商业生命週期中的包装策略。随着产品有效载荷的日益多样化，包装必须在严格的热性能、成本、永续性和操作实用性之间取得平衡。

了解近期技术进步和分销模式的转变如何从根本上重塑药品温控包装策略和采购决策。

近年来，医药供应链中温控包装的概念、采购和运作方式发生了变革性转变。主动冷却系统的创新延长了低温运输的有效持续时间，从而实现了更长的运输时间和更大的路线柔软性。同时，被动系统（先进相变材料和真空绝热板）的创新在提高性能的同时，降低了有效载荷的重量和体积。总而言之，这些技术进步显着改变了成本、风险和碳足迹之间的权衡关係。

评估近期美国关税调整对药品温控包装的采购、设计和物流策略的广泛而复杂的影响

2025年美国关税政策的发展将对医药供应链中温控包装的成本结构和筹资策略产生累积影响。原材料和成品组件的关税调整将增加到岸成本并加剧价格波动，迫使采购团队重新评估供应商组成和总到岸成本的计算。为此，许多企业正在增加供应商多元化和近岸外包的力度，以降低关税引发的价格波动风险，同时维持服务水准。

从包装类型、温度范围到隔热材料、运输方式和最终用户需求等不同的细分维度，如何导致差异化的包装策略和采购决策。

细分市场层面的趋势揭示了不同的性能和应用模式，相关人员在选择温控包装时应考虑这些因素。按包装类型评估，主动式和被动式解决方案相辅相成。主动式解决方案，例如干冰系统和冷媒盒，非常适合需要持续低温和长途运输的货物。而被动式解决方案，无论是可重复使用或一次性使用，通常都能在短距离运输中优化操作简便性、降低初始成本并减少搬运风险。

全球市场在基础设施、法规和供应链成熟度方面的区域差异正在影响温控包装的采用模式和策略重点。

区域趋势既影响特定技术的可用性，也影响影响包装选择的物流限制。在美洲，对温控治疗药物和先进物流基础设施日益增长的需求，推动了遥测包装和可重复使用系统的广泛应用，这些系统可以整合到现有的低温运输网路中。随着分销范围的扩大，扩充性、合规性和最后一公里可靠性在这里变得至关重要。

供应商创新、跨产业伙伴关係以及「即服务」经营模式将如何重塑竞争格局并加速整合温控包装解决方案的普及应用？

主要企业之间竞争与合作的动态关係正在重新定义包装解决方案的设计、检验和上市方式。领先的供应商正投资于整合热工程、遥测技术和生命週期服务模式的综合解决方案，为製药客户提供承包解决方案。这一趋势正在促进包装专家、材料创新者和物流供应商之间的伙伴关係，以确保端到端的无缝性能和责任落实。

为采购、品质和物流领导者提供切实可行的策略行动，以增强韧性、降低拥有成本并与监管和永续性优先事项保持一致。

产业领导者可以采取多项切实可行的措施来提高韧性、降低整体拥有成本并实现监管和永续性目标。首先，在药物研发早期就应将包装决策纳入考量，使热保护要求与有效载荷敏感性、剂型和商业分销策略保持一致。儘早进行调整可以减少重新设计週期，并加快产品上市速度，同时确保供应链合作伙伴能够在规模化生产之前检验流程。

调查方法概述：本研究采用混合方法，结合一手访谈、技术检验和监管整合，为企业决策者提供实用见解。

本报告采用混合研究途径，结合了访谈、技术检验以及对已发布的监管指南和标准的系统性回顾。主要资料来源包括对供应链负责人、包装工程师、临床物流经理和高级采购人员的结构化访谈，以便能够对实务经验、挑战和创新重点进行三角验证。这些第一手观点被用于情境分析，并评估不同温度曲线和运输方式下的设计权衡。

总之，我们强调，有必要将温控包装纳入端到端的产品生命週期规划中，以保护价值并确保连续性。

高效的温控包装如今在药品完整性、法规遵循性和商业性分销方面发挥核心作用。主动式和被动式系统的技术进步，以及对可追溯性和永续性严格的要求，已使包装成为贯穿研发、临床和商业供应链的策略性考量。因此，决策者在选择解决方案时必须权衡热性能、操作可行性和环境影响。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依包装类型分類的药品温控包装解决方案市场

  • 活性解决方案
    • 干冰系统
    • 冷媒盒
  • 被动解决方案
    • 可重复使用的
    • 一次性

9. 依温度范围分類的药品温控包装解决方案市场

  • 冷藏温度
  • 管制室温
  • 冰冻温度

第十章：以隔热材料分類的医药温控包装解决方案市场

  • 发泡聚苯乙烯
  • 相变材料
    • 共晶溶液
    • 无机物
    • 有机的
  • 真空绝热板

第十一章：以运输方式分類的药品温控包装解决方案市场

  • 空运货物
  • 陆运
    • 铁路运输
    • 道路运输
  • 海上运输

第十二章：以最终用户分類的医药温控包装解决方案市场

  • 临床研究所
    • 第一、二期设施
    • 三期至四期设施
  • 批发商
  • 製药公司
  • 连锁药局

第十三章：按地区分類的医药温控包装解决方案市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：依组别分類的药品温控包装解决方案市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国医药温控包装解决方案市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国药品温控包装解决方案市场

第十七章：中国医药温控包装解决方案市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Berry Global, Inc.
  • Cold Chain Technologies, Inc.
  • Cryopak, Inc.
  • Envirotainer AB
  • Pelican Products, Inc.
  • Polar Tech Industries, LLC
  • Sealed Air
  • Softbox Systems Ltd.
  • Sonoco Products Company
  • Thermo Fisher Scientific, Inc.
  • va-Q-tec AG
Product Code: MRR-4F7A6D4FF385

The Pharmaceuticals Temperature Controlled Packaging Solutions Market was valued at USD 14.91 billion in 2025 and is projected to grow to USD 15.96 billion in 2026, with a CAGR of 7.15%, reaching USD 24.19 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.91 billion
Estimated Year [2026] USD 15.96 billion
Forecast Year [2032] USD 24.19 billion
CAGR (%) 7.15%

Framing the evolving role of temperature-controlled packaging in pharmaceuticals as a strategic enabler for product integrity, sustainability, and supply chain resilience

The pharmaceutical cold chain environment demands packaging solutions that protect product integrity while aligning with evolving regulatory, logistical, and commercial requirements. Advances in biologics, cell and gene therapies, and temperature-sensitive small molecules have increased the complexity of distribution, prompting stakeholders to reassess packaging strategies across clinical and commercial lifecycles. As product payloads diversify, packaging must reconcile strict thermal performance with cost, sustainability, and operational practicality.

Effective introduction requires an appreciation of the multiple interdependent pressures shaping the category. Regulatory scrutiny of temperature excursions, the growth of decentralized clinical trials, and the push for lower carbon logistics have converged to elevate packaging from a tactical commodity to a strategic enabler. Consequently, procurement, quality, and logistics leaders now collaborate earlier in product development to specify solutions that balance thermal protection, handling ergonomics, and end-to-end visibility.

Understanding how recent technological advances and shifting distribution models are fundamentally reshaping pharmaceutical temperature-controlled packaging strategies and procurement decisions

Recent years have produced transformative shifts in how temperature-controlled packaging is conceptualized, procured, and operated across pharmaceutical supply chains. Technological innovation in active cooling systems has expanded viable cold-chain windows, enabling longer shipments and more flexible routing. At the same time, innovations in passive systems-advanced phase change materials and vacuum insulated panels-have improved performance while reducing payload weight and volume. These technology advances, when taken together, have materially altered tradeoffs between cost, risk, and carbon footprint.

Concurrently, market dynamics such as the decentralization of clinical trials and the rapid increase in direct-to-patient deliveries have reshaped demand profiles. Logistics providers are optimizing modal mixes and last-mile capabilities to accommodate smaller, more frequent shipments. In parallel, regulatory expectations for chain-of-custody documentation and real-time temperature monitoring have raised the bar for packaging that integrates telemetry and tamper-evident features. Together, these developments are pushing stakeholders to adopt modular, scalable solutions that can be tailored to diverse product temperature profiles and shipment scenarios.

Evaluating the broad and compounding effects of recent United States tariff adjustments on sourcing, design, and logistical strategies for pharmaceutical temperature-controlled packaging

United States tariff policy developments in 2025 have cumulative implications for the cost structure and sourcing strategies of temperature-controlled packaging within pharmaceutical supply chains. Tariff adjustments on raw materials and finished components increase landed costs and introduce price volatility, prompting procurement teams to reassess supplier footprints and total landed cost calculations. In response, many organizations intensify supplier diversification and nearshoring efforts to mitigate exposure to tariff-driven price swings while preserving service levels.

Moreover, tariffs incentivize re-evaluation of material choices and design decisions. For instance, increased import costs for certain insulation substrates or active system components can accelerate substitution toward locally produced alternatives or recycled feedstocks where technical performance permits. Simultaneously, logistics strategies adapt: longer domestic transit routes may become more attractive relative to cross-border shipments subject to tariff differentials, and carriers and packagers collaborate to redesign packaging to reduce weight and dimensional profiles. Overall, these shifts cultivate a more regionally optimized supply base and elevate strategic sourcing as a critical lever for cost control and continuity of supply.

How distinct segmentation dimensions-from packaging type and temperature range to insulation material, shipping mode, and end-user requirements-drive differentiated packaging strategies and procurement decisions

Segment-level dynamics reveal distinct performance and adoption patterns that industry stakeholders must consider when specifying temperature-controlled packaging. When assessed by packaging type, both active solutions and passive solutions play complementary roles: active solutions, including dry ice systems and refrigerant cartridges, suit shipments requiring sustained low-temperature control or extended transit durations, whereas passive solutions, whether reusable or single-use, often optimize for operational simplicity, lower upfront cost, and lower handling risk on shorter routes.

Temperature range segmentation clarifies selection criteria; chilled temperature options are tailored to many biologics and vaccines that require narrow refrigerated windows, controlled room temperature solutions address many small-molecule formulations where thermal stability is maintained within a defined ambient band, and frozen temperature systems are indispensable for cryogenic or frozen payloads. Insulation material distinctions further inform design choices: expanded polystyrene remains a widely used option for certain single-use applications; phase change materials-encompassing eutectic solutions as well as inorganic and organic formulations-offer engineered thermal buffers for precise hold times; and vacuum insulated panels deliver high performance where space and mass efficiency are paramount. Shipping mode considerations influence packaging robustness and regulatory compliance; air freight, land transport, and sea freight each impose different shock, vibration, and thermal ramp profiles, with land transport subdivided into rail and road choices that affect transit predictability and cold chain continuity. Finally, end-user segmentation demonstrates divergent priorities: clinical research organizations, including both Phase I-II and Phase III-IV facilities, prioritize flexibility and traceability, while distributors, pharmaceutical manufacturers, and pharmacy chains emphasize cost efficiency, handling simplicity, and integration with existing logistics and quality processes.

Regional nuances in infrastructure, regulation, and supply chain maturity shaping divergent adoption patterns and strategic priorities for temperature-controlled packaging across global markets

Regional dynamics shape both the availability of specific technologies and the logistical constraints that influence packaging selection. In the Americas, growing demand for temperature-sensitive therapies and advanced logistics infrastructure favor higher adoption of telemetry-enabled packaging and reusable systems that can be integrated into established cold-chain networks. The emphasis here is on scalability, regulatory compliance, and last-mile reliability as distribution footprints expand.

Across Europe, the Middle East & Africa, regulatory harmonization efforts and sustainability agendas are driving interest in low-carbon solutions and materials with end-of-life recovery pathways. In these markets, a balanced mix of high-performance passive materials and active systems addresses a wide diversity of climatic conditions and transit modalities. The Asia-Pacific region is characterized by rapid biopharma manufacturing growth and fragmented logistics networks, which together increase demand for adaptable packaging solutions capable of supporting long multimodal supply chains. Emerging hubs invest in local manufacturing and material alternatives to reduce cycle time and exposure to cross-border constraints, thereby accelerating adoption of regionally optimized packaging strategies.

How supplier innovation, cross-industry partnerships, and as-a-service commercial models are reshaping competitive dynamics and accelerating integrated temperature-controlled packaging solutions

Competitive and collaborative dynamics among key companies are redefining how packaging solutions are engineered, validated, and brought to market. Leading suppliers are investing in integrated offerings that combine thermal engineering, telemetry, and lifecycle service models to provide turn-key solutions for pharmaceutical customers. This trend favors partnerships between packaging specialists, materials innovators, and logistics providers to ensure seamless end-to-end performance and accountability.

At the same time, innovation pathways include modular product architectures and as-a-service commercial models that reduce capital burden on customers while enabling continuous performance improvement. Strategic collaborations with clinical trial sponsors and contract logistics providers accelerate product qualification cycles, while investments in transparent validation protocols enhance confidence for regulatory submissions. Collectively, these competitive behaviors elevate the role of service, traceability, and sustainability as differentiators in a maturing supplier landscape.

Practical strategic actions for procurement, quality, and logistics leaders to strengthen resilience, lower ownership costs, and align packaging with regulatory and sustainability priorities

Industry leaders can take several pragmatic actions to improve resilience, reduce total cost of ownership, and meet regulatory and sustainability objectives. First, integrate packaging decisions earlier in drug development to align thermal protection requirements with payload sensitivity, dosing formats, and commercial distribution strategies. Early alignment reduces redesign cycles and shortens time to market while ensuring supply chain partners can validate processes ahead of scale-up.

Second, evolve sourcing strategies to incorporate supplier diversification and regional manufacturing where feasible, thereby reducing exposure to tariff volatility and single-source disruptions. Third, adopt modular packaging platforms and telemetry standards to enhance reuse potential and simplify qualification. Fourth, prioritize materials that balance thermal performance with recyclability or reuse potential, and embed life-cycle assessment metrics into procurement evaluations. Finally, strengthen cross-functional governance with clear accountability for packaging performance, excursion remediation, and continuous improvement to ensure operational lessons are rapidly captured and applied across programs.

Methodological overview detailing mixed-methods research combining primary interviews, technical validation, and regulatory synthesis to produce actionable insights for operational decision-makers

The report synthesis draws on a mixed-methods research approach that combines primary interviews, technical validation, and a structured review of publicly available regulatory guidance and standards. Primary inputs include structured interviews with supply chain leaders, packaging engineers, clinical logistics managers, and senior procurement executives, enabling triangulation of practical experiences, pain points, and innovation priorities. These first-hand perspectives inform scenario analysis and the assessment of design tradeoffs across temperature profiles and shipment modalities.

Technical validation involved laboratory performance data provided by manufacturers and independent testing facilities, assessing thermal hold times, impact resistance, and integration of telemetry systems. To ensure contextual accuracy, the research also incorporates a comparative review of regional regulatory frameworks and industry guidance relevant to chain-of-custody, temperature excursion remediation, and packaging validation. This layered methodology supports balanced, actionable findings and recommendations tailored to operational decision-makers.

Concluding perspective emphasizing the strategic imperative of integrating temperature-controlled packaging into end-to-end product lifecycle planning to protect value and ensure continuity

Effective temperature-controlled packaging is now central to pharmaceutical product integrity, regulatory compliance, and commercial delivery. Technological advances in active and passive systems, coupled with more exacting expectations for traceability and sustainability, have elevated packaging as a strategic consideration across development, clinical, and commercial supply chains. Decision-makers must therefore balance thermal performance, operational feasibility, and environmental impact when choosing solutions.

Looking ahead, the intersection of policy shifts, evolving distribution models, and material innovation will continue to reshape supplier selection and sourcing approaches. Organizations that proactively integrate packaging strategy into early development decisions, diversify supply bases to manage geopolitical and tariff risks, and adopt circularity principles where appropriate will be better positioned to preserve product quality while optimizing cost and carbon outcomes. In short, packaging strategy must evolve from transactional procurement to an integral component of product lifecycle management.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceuticals Temperature Controlled Packaging Solutions Market, by Packaging Type

  • 8.1. Active Solutions
    • 8.1.1. Dry Ice Systems
    • 8.1.2. Refrigerant Cartridges
  • 8.2. Passive Solutions
    • 8.2.1. Reusable
    • 8.2.2. Single Use

9. Pharmaceuticals Temperature Controlled Packaging Solutions Market, by Temperature Range

  • 9.1. Chilled Temperature
  • 9.2. Controlled Room Temperature
  • 9.3. Frozen Temperature

10. Pharmaceuticals Temperature Controlled Packaging Solutions Market, by Insulation Material

  • 10.1. Expanded Polystyrene
  • 10.2. Phase Change Materials
    • 10.2.1. Eutectic Solutions
    • 10.2.2. Inorganic
    • 10.2.3. Organic
  • 10.3. Vacuum Insulated Panels

11. Pharmaceuticals Temperature Controlled Packaging Solutions Market, by Shipping Mode

  • 11.1. Air Freight
  • 11.2. Land Transport
    • 11.2.1. Rail Transport
    • 11.2.2. Road Transport
  • 11.3. Sea Freight

12. Pharmaceuticals Temperature Controlled Packaging Solutions Market, by End User

  • 12.1. Clinical Research Organizations
    • 12.1.1. Phase I-II Facilities
    • 12.1.2. Phase III-IV Facilities
  • 12.2. Distributors
  • 12.3. Pharma Manufacturers
  • 12.4. Pharmacy Chains

13. Pharmaceuticals Temperature Controlled Packaging Solutions Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pharmaceuticals Temperature Controlled Packaging Solutions Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pharmaceuticals Temperature Controlled Packaging Solutions Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Pharmaceuticals Temperature Controlled Packaging Solutions Market

17. China Pharmaceuticals Temperature Controlled Packaging Solutions Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Berry Global, Inc.
  • 18.6. Cold Chain Technologies, Inc.
  • 18.7. Cryopak, Inc.
  • 18.8. Envirotainer AB
  • 18.9. Pelican Products, Inc.
  • 18.10. Polar Tech Industries, LLC
  • 18.11. Sealed Air
  • 18.12. Softbox Systems Ltd.
  • 18.13. Sonoco Products Company
  • 18.14. Thermo Fisher Scientific, Inc.
  • 18.15. va-Q-tec AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY DRY ICE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY DRY ICE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY DRY ICE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY REFRIGERANT CARTRIDGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY REFRIGERANT CARTRIDGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY REFRIGERANT CARTRIDGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CHILLED TEMPERATURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CHILLED TEMPERATURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CHILLED TEMPERATURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY FROZEN TEMPERATURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY FROZEN TEMPERATURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY FROZEN TEMPERATURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY EXPANDED POLYSTYRENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY EXPANDED POLYSTYRENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY EXPANDED POLYSTYRENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY EUTECTIC SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY EUTECTIC SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY EUTECTIC SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INORGANIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INORGANIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INORGANIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ORGANIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ORGANIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ORGANIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY VACUUM INSULATED PANELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY VACUUM INSULATED PANELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY VACUUM INSULATED PANELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY AIR FREIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY AIR FREIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY AIR FREIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY RAIL TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY RAIL TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY RAIL TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ROAD TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ROAD TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ROAD TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SEA FREIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SEA FREIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SEA FREIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE I-II FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE I-II FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE I-II FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE III-IV FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE III-IV FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE III-IV FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHARMA MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHARMA MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHARMA MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHARMACY CHAINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHARMACY CHAINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHARMACY CHAINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 191. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 194. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 195. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 197. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 198. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 200. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 224. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 227. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 228. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 230. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 231. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 233. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-